Form 4: Rhythm Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals, sold 15,515 shares of common stock on March 19, 2024, to cover withholding taxes related to vesting restricted stock units.

Summary

• Joseph Shulman, the Chief Technical Officer of Rhythm Pharmaceuticals, sold 15,515 shares of the company's common stock on March 19, 2024.
• The sale was executed to cover withholding taxes associated with the vesting of previously reported restricted stock units.
• The shares were sold at a weighted average price of $39.22, with individual transactions ranging from $39.06 to $39.22 per share.
• Following the transaction, Shulman directly owns 18,265 shares of Rhythm Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't inherently reflect a positive or negative view of the company's prospects.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself doesn't necessarily indicate a negative outlook on the company's future, but it's a transaction investors often monitor.

Stakeholder Impact

• The sale could have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small volume of shares sold.

Key Dates